GlassScriptPhysician profile
Suhel H Ahmed
NPI 1801042072
$82,385.77
in general payments reported to CMS, 2019-2025
64 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,533 · 2020: $522 · 2021: $1,782 · 2022: $7,100 · 2023: $8,967 · 2024: $24K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $49K · Honoraria: $11K · Food and Beverage: $9,051 · Travel and Lodging: $2,602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $49,295.16 |
| Honoraria | $10,500.00 |
| Food and Beverage | $9,051.48 |
| Travel and Lodging | $2,602.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $62,761.73 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Intra-Sana Laboratories | $11,431.19 | 2022-2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Pfizer INC. | $744.97 | 2019-2025 | |
| Boston Scientific Corporation | $698.45 | 2021-2025 | Watchman Flx, Ams 700, Lux-Dx Insertable Cardiac Monitor |
| Abbvie INC. | $490.57 | 2021-2025 | Qulipta, Vraylar, Ubrelvy |
| Exact Sciences Corporation | $384.75 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $357.90 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $351.49 | 2019-2025 | Wainua, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $311.44 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $292.90 | 2023-2025 | |
| Daiichi Sankyo INC. | $247.01 | 2019-2025 | Injectafer |
| Biosense Webster, INC. | $225.72 | 2019 | |
| Abbott Laboratories | $216.64 | 2019-2024 | Eterna, Proclaim, Freestyle Libre |
| Lilly USA, LLC | $216.54 | 2022-2025 | Mounjaro, Zepbound |
| Medtronic, INC. | $213.14 | 2023-2025 | Symplicity G3, Appose Ulc |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $198.89 | 2019-2021 | |
| Gilead Sciences, INC. | $189.59 | 2019-2025 | |
| Axsome Therapeutics, INC. | $170.89 | 2025 | Symbravo, Auvelity |
| Asensus Surgical, INC. | $166.49 | 2022-2023 | Senhance |
| Dexcom, INC. | $165.56 | 2025 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $161.43 | 2025 | Korlym |
| Biotronik Nro, INC. | $151.37 | 2023-2025 | Biotronik, Prospera |
| Abiomed | $148.21 | 2024 | Impella |
| Qapel Medical INC | $147.27 | 2024 | |
| Novartis Pharmaceuticals Corporation | $140.63 | 2019-2022 | |
| Lexicon Pharmaceuticals, INC. | $124.97 | 2024 | Inpefa |
| Amgen INC. | $121.15 | 2019-2023 | Repatha, Otezla |
| Currax Pharmaceuticals LLC | $110.52 | 2023-2024 | Contrave |
| Allergan, INC. | $110.38 | 2020 | |
| Astellas Pharma US INC | $104.08 | 2023-2025 | Veozah |
| Amneal Pharmaceuticals LLC | $100.00 | 2021 | |
| Amarin Pharma, INC. | $92.28 | 2019-2022 | |
| Vivus LLC | $88.84 | 2019-2023 | Qsymia |
| Endo Pharmaceuticals INC. | $71.70 | 2021-2022 | |
| Philips North America LLC | $61.95 | 2024-2025 | (Ck7) Extended Holter, Mcot |
| Merck Sharp & Dohme LLC | $60.00 | 2019-2025 | Verquvo, Steglatro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.47 | 2019-2025 | Xifaxan, Trulance |
| Biohaven Pharmaceuticals, INC. | $57.85 | 2021 | |
| Arbor Pharmaceuticals, INC. | $54.07 | 2020-2022 | |
| Otsuka America Pharmaceutical, INC. | $53.26 | 2021-2022 | |
| Phadia US INC. | $47.86 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $44.24 | 2022 | |
| Viiv Healthcare Company | $36.95 | 2023-2025 | Apretude |
| Kerecis Limited | $36.47 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Intuity Medical INC | $35.55 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Horizon Therapeutics Plc | $28.01 | 2021-2022 | |
| Insightec,INC | $27.61 | 2025 | Exablate |
| Nalpropion Pharmaceuticals LLC | $25.48 | 2019 | |
| Inspire Medical Systems, INC. | $21.03 | 2025 | Inspire |
| Phathom Pharmaceuticals, INC. | $19.00 | 2025 | Voquezna |
| Bausch Health US, LLC | $18.29 | 2025 | Aplenzin |
| Invivyd INC | $18.00 | 2025 | Pemgarda |
| 3b Medical, INC. | $17.97 | 2025 | Luna |
| Mannkind Corporation | $15.96 | 2025 | |
| Rhythm Pharmaceuticals, INC. | $15.76 | 2025 | Imcivree |
| Medtronic Minimed, INC. | $15.13 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.60 | 2020 | |
| Azurity Pharmaceuticals, INC. | $14.50 | 2023 | Horizant |
| Takeda Pharmaceuticals U.S.A., INC. | $14.40 | 2022 | |
| Xeris Pharmaceuticals, INC. | $13.62 | 2024 | Keveyis |
| Csl Behring | $13.19 | 2022 | |
| Sanofi-Aventis U.S. LLC | $12.99 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.52 | 2021 | |
| Echosens North America, INC. | $11.35 | 2025 | Fibroscan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suhel Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.